In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Immunocore Holdings, with a price target of $100.00. The company’s shares opened today at $31.80.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Trucchio covers the Healthcare sector, focusing on stocks such as Arrowhead Pharmaceuticals, Precision BioSciences, and Aligos Therapeutics. According to TipRanks, Trucchio has an average return of 28.1% and a 51.13% success rate on recommended stocks.
Immunocore Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $59.11.
The company has a one-year high of $39.33 and a one-year low of $23.15. Currently, Immunocore Holdings has an average volume of 308.3K.
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/AI%20(artificial%20intelligence)/AI%20engineer%20working%20on%20laptop%20by%20ART%20STOCK%20CREATIVE%20via%20Shutterstock.jpg)
/Salesforce%20Inc%20HQ%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)